Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/19/2011

financial results. A slide presentation accompanying the conference call is available through the "Investors" section of Amylin's corporate website at www.amylin.com.

To access the webcast, please log on to www.amylin.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (800) 857-5738 (U.S./Canada) or (415) 228-4970 (international), participant passcode number 7156306. A replay of the call will also be available by phone beginning approximately two hours after the close of the call and can be accessed at (866) 415-3327 (U.S./Canada) or (203) 369-0696 (international).

Note Regarding Use of Non-GAAP Financial Measures Amylin reports non-GAAP operating income or loss excluding non-cash items and other items such as restructuring charges, which is a non-GAAP financial measure. The Company believes that investors' understanding of its progress towards its stated goal of generating sustainable positive non-GAAP operating results is enhanced by this disclosure. In addition, the Company refers to this non-GAAP financial information with its analysis of the Company's financial performance. This non-GAAP financial measure should be considered in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP.  

About Amylin PharmaceuticalsAmylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Third Quarter Results
2. Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
3. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
4. Amylin Pharmaceuticals to Webcast Second Quarter Results
5. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
6. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
7. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
8. Lilly Comments on Court Ruling in Amylin Litigation
9. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
10. Lilly Provides Its Perspective in Response to Amylin Lawsuit
11. Lilly Provides Statement in Response to Amylin Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) ... Devices Packaging Market - By Packaging type, Regions and ... report to their offering. The ... by its end use industry, i.e., Medical devices industry. ... these devices so as to be tamper evident, and ...
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tzzq39/investigation ... Report on China,s Trastuzumab Market, 2010-2019" report to ... approved by FDA to be used in the clinic ... a major product of Roche. In 2013, the sales ... world. After entering China ...
(Date:9/3/2015)... -- China,s startup business ExtantFuture ... wearable medical device that can continuously monitor the fetal ... guidance for pregnant women. The device will debut on ... measures 4 centimeters in diameter, is as thin as ... an Apple earphone cord. The small and compact device ...
Breaking Medicine Technology:Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2
... - Antigenics Inc.,(NASDAQ: AGEN) today announced additional ... therapeutic cancer vaccine,Oncophage(R) (vitespen). The end-of-study results, ... showed that in a substantial,subset of patients ... disease,recurrence, Oncophage demonstrated a clinically significant,improvement in ...
... product recently approved by FDA for long-term,maintenance ... formoterol fumarate provides improved lung function,comparable to ... and positive safety profile -- , NAPA, ... at the,International Conference of the American Thoracic ...
Cached Medicine Technology:Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
(Date:9/3/2015)... GA (PRWEB) , ... September 03, 2015 , ... ... cover the cost of graduated compression garments. However, graduated compression garments are an ... Wound care and lymphedema specialist, Robyn Bjork, was recently sponsored by SIGVARIS ...
(Date:9/3/2015)... ... 03, 2015 , ... RealtyShares , the online marketplace ... investors to real estate investment opportunities nationwide, today announced that it is introducing ... and sponsoring real estate companies. , These products typically involve investors ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... The first ... covering the allegations made by IVC filter lawsuits filed against Bard.** These ... harmed when a Bard IVC filter broke or failed, have recently been consolidated for ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Linda Hall Library ... of a comet, the IceCube observatory at the South Pole, and the interior of ... Fall Lecture Series for the world's foremost independently funded research library devoted to science, ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... of comprehensive eating disorder treatment for adults and adolescents struggling with anorexia, ... MD has joined the medical treatment team. As a Staff Psychiatrist, Dr. ...
Breaking Medicine News(10 mins):Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3
... of Vulnerability Management and Operational Whitelisting and Discuss Today,s ... ... Scottsdale, Ariz. (PRWEB) August ... __title__ Vulnerability Management Solutions], a recognized, global leader in ...
... allergies aren,t avoiding the foods they know they shouldn,t eat. ... epinephrine as often as they should be. And instructors, roommates ... if a food-allergic student has a reaction. , These are ... of Michigan Health System. The research suggests that many college ...
... Scott Kornhauser,announced the appointment of Marquita Collins as ... than 20 years of,healthcare industry experience., Her ... of,Aptiv Technology Partners and Regional Operations Director for ... and managing the,entire professional services team and full ...
... NCST ; TSX: NCS), a developer and manufacturer of ... financial results for the second quarter 2008 on Tuesday, August ... 9:00 AM ET on Wednesday,August 13, 2008 to discuss the ... Date: Wednesday, ...
... nevirapine could have downside, study finds , , TUESDAY, Aug. ... used in developing countries to prevent transmission of ... breast milk and blood of mothers, a new Stanford ... the risk that they and their children will develop ...
... emphasize measurement gaps and harmonization, WASHINGTON, ... assessing,clinician performance that can promote higher quality ... endorsed 67 clinician-level consensus,standards relating to cancer ... by thousands of medical professionals who are ...
Cached Medicine News:Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 2Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 3Health News:Students with food allergies often not prepared 2Health News:Students with food allergies often not prepared 3Health News:NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008 2Health News:HIV Drug Might Spur Resistant Strains of Virus 2Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 2Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 3Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 4Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 5Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 6Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 7Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 8Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 9Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 10Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 11
MBP's 200 ul large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
... an innovative, quick and easy automated ... 60% less space on your laboratory ... this amazingly easy-to-use, one-hand system, you ... whole range of Diamond Tips. All ...
... innovative, quick and easy automated refill ... less space on your laboratory bench ... amazingly easy-to-use, one-hand system, you only ... range of Diamond Tips. All sizes ...
10 L, Racked, 96 tips/rack Extended length pipette tips recommended for 5 and 10 L pipettes....
Medicine Products: